Denied

No. 19-1061

<span>Docketed:</span><span>February 26, 2020</span> v. Eli Lilly and Company

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

Reply of petitioners Dr. Reddy's Laboratories, Ltd., et al. filed. (Distributed)

DISTRIBUTED for Conference of 6/11/2020.

Motion to delay distribution of the petition for a writ certiorari until May 26, 2020, granted.

Motion of petitioners to delay distribution of the petition for a writ of certiorari under Rule 15.5 from May 12, 2020 to May 26, 2020, submitted to The Clerk.

Brief of respondents Eli Lilly & Company in opposition filed. VIDED.

Brief amicus curiae of Association for Accessible Medicines filed.

Brief amicus curiae of America's Health Insurance Plans filed.

Brief amicus curiae of R Street Institute filed. VIDED.

Motion to extend the time to file a response is granted and the time is extended to and including April 27, 2020.

Motion to extend the time to file a response from March 27, 2020 to April 27, 2020, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due March 27, 2020)

Application (19A818) granted by The Chief Justice extending the time to file until February 24, 2020.

Application (19A818) to extend the time to file a petition for a writ of certiorari from February 6, 2020 to February 24, 2020, submitted to The Chief Justice.

Parties

Dr. Reddy's Laboratories, Ltd., et al., Petitioner, represented by John Caviness O'Quinn

Eli Lilly & Company, Respondent, represented by Adam Lawrence Perlman

Amici Curiae

America's Health Insurance Plans, Amicus Curiae, represented by Anna-Rose Mathieson

Association for Accessible Medicines, Amicus Curiae, represented by Brian Timothy Burgess

R Street Institute, Amicus Curiae, represented by Charles Duan

 
Last updated: August 11, 2020